Drugs

New Eye-tracking Technology for Addiction Research

Alcohol is the most commonly used addictive substance in the United States, according to the National Council on Alcoholism and Drug Dependence (NCADD). One in every 12 adults, 17.6 million people, suffer from alcohol abuse or dependence. Several million more engage in risky, binge drinking patterns that could lead to alcohol problems. Looking into the reasons individuals become addicted to alcohol is why Dr. Mark Fillmore came to the University of Kentucky 17 years ago.

Fillmore’s research is a combination of psychology, behavioral neuroscience, biology and pharmacology. Looking at the differing ways individuals react to drugs of abuse, whether the drug be alcohol, marijuana, or some other drug of abuse, may give clues to why some people become dependent on a drug over time. 

For more information about psychology department go to: psychology.as.uky.edu/

 

 

Light-Activated Cancer Drugs with Chemistry's Phoebe Glazer

At the University of Kentucky, Assistant Professor of Chemistry Edith "Phoebe" Glazer is looking for something more effective at killing cancer cells and less toxic to healthy cells than cisplatin. A platinum-based drug, cisplatin is one of the most commonly used cancer drugs, but leads to nausea and nerve damage. Her alternative uses ruthenium, another transition metal, to build complex molecules. Theses molecules can be "switched on" by light from a fiber-optic probe once they reach their target tumor and would kill only cancerous cells. In January 2013, Glazer received a four-year, $715,000 grant from the American Cancer Society to develop a family of ruthenium molecules to fight different kinds of cancer.

This video appears courtesy of Reveal: University of Kentucky Research Media research.uky.edu/reveal/

Subscribe to RSS - Drugs
X
Enter your linkblue username.
Enter your linkblue password.
Secure Login

This login is SSL protected

Loading